Recipient of the 2021 Endocrine Pathology Society Lifetime Achievement Award: Dr. Ronald A. DeLellis Arthur S. TischlerSylvia LAsaOzgur Mete Announcement 01 November 2021 Pages: 429 - 431
Endocrine Pathology Society Hubert Wolfe Award for 2021: Call for Nominations Announcement 23 October 2021 Pages: 432 - 432
Middle Ear “Adenoma”: a Neuroendocrine Tumor with Predominant L Cell Differentiation Sylvia L. AsaKnarik ArkunOzgur Mete OriginalPaper 27 May 2021 Pages: 433 - 441
Immunohistochemical Expression of Choline Acetyltransferase and Catecholamine-Synthesizing Enzymes in Head-and-Neck and Thoracoabdominal Paragangliomas and Pheochromocytomas Noriko KimuraKiyoto ShigaTakayuki Katabami OriginalPaper 06 November 2021 Pages: 442 - 451
INSM1 Expression in Breast Neoplasms with Neuroedocrine Features Jasna MetovicIsabella CastellanoMauro Papotti OriginalPaper Open access 19 May 2021 Pages: 452 - 460
Reconsideration of Clinicopathologic Prognostic Factors in Pancreatic Neuroendocrine Tumors for Better Determination of Adverse Prognosis Anil AysalCihan AgalarOzgul Sagol OriginalPaper 20 July 2021 Pages: 461 - 472
Co-occurrence of Pituitary Neuroendocrine Tumors (PitNETs) and Tumors of the Neurohypophysis Wolfgang SaegerJannik von SchöningUlrich J. Knappe OriginalPaper 15 June 2021 Pages: 473 - 479
Positive Correlation of Thyroid Nodule Cytology with Molecular Profiling—a Single-Center Experience Idit TesslerIsaac ShochatGalit Avior OriginalPaper 04 June 2021 Pages: 480 - 488
Primary Versus Secondary Anaplastic Thyroid Carcinoma: Perspectives from Multi-institutional and Population-Level Data Tam N. M. NgoTrang T. B. LeHuy Gia Vuong OriginalPaper 24 September 2021 Pages: 489 - 500
Analyzing Genetic Differences Between Sporadic Primary and Secondary/Tertiary Hyperparathyroidism by Targeted Next-Generation Panel Sequencing Yu Ah HongKi Cheol ParkJoonhong Park OriginalPaper 03 July 2021 Pages: 501 - 512
TERT Promoter Mutated Follicular Thyroid Carcinomas Exhibit a Distinct microRNA Expressional Profile with Potential Implications for Tumor Progression Johan O. PaulssonJan ZedeniusC. Christofer Juhlin BriefCommunication Open access 21 October 2021 Pages: 513 - 516
Pathogenic ATM Variant-Harbouring Well-Differentiated Aggressive Type 1 Gastric Neuroendocrine Tumour with High-grade Features (G3 NET): a New Addition to the Clinical and Pathological Spectrum of Gastric Neuroendocrine Neoplasms Hussein NassereddineMatthieu ChicaudAnne Couvelard OriginalPaper 21 May 2021 Pages: 517 - 523